|1.||Wei, Yumei: 1 article (07/2014)|
|2.||Wang, Cui: 1 article (07/2014)|
|3.||Zhu, Qi: 1 article (07/2014)|
|4.||Tian, Weili: 1 article (07/2014)|
|5.||Huang, Canke: 1 article (07/2014)|
|6.||Zhang, Qingyu: 1 article (07/2014)|
|7.||Wang, Li-hua: 1 article (10/2013)|
|8.||Wang, Peng: 1 article (10/2013)|
|9.||Huang, Jian-shu: 1 article (10/2013)|
|10.||Li, Xiu-ju: 1 article (10/2013)|
10/01/2013 - "To analyze the clinical features and diagnostic points of occupational acute dimethylformamide (DMF) poisoning and to explore the mechanism of occupational acute DMF poisoning. "
10/01/2013 - "[Occupational acute dimethylformamide poisoning: an analysis of 16 cases]."
06/01/2011 - "[Clinical report of occupational acute dimethylformamide poisoning]."
10/01/2008 - "[Survey on a dimethylformamide poisoning incident in a leather processing factory]."
02/01/2005 - "[One case of hepatic disease by dimethylformamide poisoning.]."
08/01/2007 - "29 (1990) 5197-5200, for synthesis and structural characterization, DMF=dimethylformamide] (NSC #624662) by using a panel of ca. 50 human cancer cells, showed growth inhibition factor GI(50) values as low as 20microM against several cancer lines, with an average value 54.4microM. "
04/01/2000 - "Dimethylformamide (DMF) has been suspected to associate with cancers in exposed workers, whereas there has been inadequate evidence for carcinogenicity in experimental animals. "
05/01/1989 - "A case-control study of cancer among du pont employees with potential for exposure to dimethylformamide."
02/15/1989 - "The anti-tumor activity of the putative differentiation-inducing agent dimethylformamide (DMF) was assessed in 7 head-and-neck xenograft (HNX) lines transplanted into nude mice. "
05/01/1989 - "This case-control study was undertaken to determine whether the risk of developing cancers of the buccal cavity and pharynx (N = 39), liver (N = 6), prostate (N = 43), testis (N = 11), or malignant melanoma of the skin (N = 39) is related to exposure to dimethylformamide (DMF). "
|3.||Testicular Neoplasms (Testicular Cancer)
10/01/2010 - "Lastly, solvent exposure, particularly to dimethylformamide, has been suggested to be associated with testicular cancer, but almost all these studies are based on job title only, with no specific assessment of solvent exposure. "
11/17/1990 - "Testicular cancer, dimethylformamide, and leather tanneries."
01/02/1988 - "Dimethylformamide and testicular cancer."
11/14/1987 - "Testicular cancer in leather tanners exposed to dimethylformamide."
04/22/1989 - "Dimethylformamide, metal dyes, and testicular cancer."
|4.||Dehydration (Water Stress)
01/01/2010 - "After dehydration with dimethylformamide, the specimens are embedded in LR-White resin. "
05/01/1993 - "The fluorescent abamectin derivative is formed by dehydration with trifluoroacetic anhydride-1-methylimidazole in dimethylformamide for 1 h at 30 degrees C and with methanolic ammonium hydroxide for another 30 min at 30 degrees C. "
08/01/1995 - "Electron microscopic studies demonstrated that, when added with complement, pentameric IgM, but not monomeric IgM, stabilized the bacterial capsule to the dehydration in dimethylformamide used for embedding in Lowicryl K4M. "
03/04/1977 - "On the basis of the biochemical findings the azoindoxyl technique can be recommended for the histochemical demonstration of acid beta-galactosidase: 7.5 mg (1.5 mM) 5-Br-4-Cl-3-indolyl-beta-D-galactoside (dissolved in 0.25 ml dimethylformamide) and 0.05-0.15 ml hexazonium-p-rosaniline in 10 ml 0.1 M citric acid-phosphate buffer, pH 4. After incubation the sections can be treated with osmium tetroxide followed by dehydration and mounting in resins or can be mounted without prior osmification of the azoindoxyl dye in glycerin jelly. "
|5.||Digestive System Diseases
|4.||Sulfhydryl Compounds (Thiols)
|6.||Immunoglobulin M (IgM)
|7.||Complement System Proteins (Complement)
|8.||Lowicryl 4KM resin
|9.||Dimethyl Sulfoxide (DMSO)
|1.||Euthanasia (Mercy Killing)
|2.||Heterologous Transplantation (Xenotransplantation)